Credit Suisse Ag Biogen Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Biogen Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 291,725 shares of BIIB stock, worth $50.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

291,725

Previous 318,421 8.38%

Holding current value

$50.7 Million

Previous $82.4 Million 23.66%

% of portfolio

0.06%

Previous 0.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$212.02 - $267.71 $5.66 Million - $7.15 Million	-26,696 Reduced 8.38%	291,725 $62.9 Million
Q4 2023 Feb 08, 2024	SELL	$222.59 - $267.94 $6.74 Million - $8.12 Million	-30,290 Reduced 8.69%	318,421 $82.4 Million
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $680,110 - $767,614	-2,685 Reduced 0.76%	348,711 $89.6 Million
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $633,900 - $732,492	2,303 Added 0.66%	351,396 $100 Million
Q1 2023 May 10, 2023	SELL	$256.56 - $292.34 $2.89 Million - $3.29 Million	-11,263 Reduced 3.13%	349,093 $97.1 Million
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $15.5 Million - $18.8 Million	61,320 Added 20.51%	360,356 $99.8 Million
Q3 2022 Nov 10, 2022	SELL	$194.69 - $268.46 $6.38 Million - $8.8 Million	-32,765 Reduced 9.87%	299,036 $79.8 Million
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $2.51 Million - $2.99 Million	-13,389 Reduced 3.88%	331,801 $67.7 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $9.06 Million - $11.4 Million	46,761 Added 15.67%	345,190 $72.7 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $1.45 Million - $1.86 Million	6,454 Added 2.21%	298,429 $71.6 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $5.92 Million - $7.72 Million	20,909 Added 7.71%	291,975 $82.6 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $2.17 Million - $3.48 Million	-8,392 Reduced 3.0%	271,066 $93.9 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $24.5 Million - $28.7 Million	-100,801 Reduced 26.51%	279,458 $78.2 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $3.39 Million - $5.11 Million	-14,360 Reduced 3.64%	380,259 $93.1 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $22.5 Million - $25.9 Million	-84,792 Reduced 17.69%	394,619 $112 Million
Q2 2020 Aug 12, 2020	BUY	$258.66 - $342.55 $3.91 Million - $5.18 Million	15,124 Added 3.26%	479,411 $128 Million
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $4.46 Million - $5.65 Million	-16,581 Reduced 3.45%	464,287 $147 Million
Q4 2019 Feb 12, 2020	SELL	$220.06 - $304.07 $6.02 Million - $8.32 Million	-27,354 Reduced 5.38%	480,868 $143 Million
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $6.68 Million - $7.5 Million	-30,736 Reduced 5.7%	508,222 $118 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $1.8 Million - $1.98 Million	8,187 Added 1.54%	538,958 $126 Million
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $19.6 Million - $30.7 Million	90,627 Added 20.59%	530,771 $125 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $5.61 Million - $7.11 Million	20,151 Added 4.8%	440,144 $132 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $665,680 - $870,526	-2,268 Reduced 0.54%	419,993 $148 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $13.4 Million - $16 Million	-52,085 Reduced 10.98%	422,261 $123 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $5.7 Million - $8.06 Million	21,908 Added 4.84%	474,346 $130 Million
Q4 2017 Mar 14, 2018	BUY	$307.64 - $344.58 $984,448 - $1.1 Million	3,200 Added 0.71%	452,438 $144 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $10.1 Million - $11.3 Million	-32,825 Reduced 6.81%	449,238 $143 Million
Q3 2017 Nov 14, 2017	SELL	$281.15 - $329.69 $4.71 Million - $5.52 Million	-16,743 Reduced 3.36%	482,063 $151 Million
Q2 2017 Aug 14, 2017	BUY	N/A	498,806	498,806 $135 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account